sb 203580 has been researched along with l-165041 in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (l-165041) | Trials (l-165041) | Recent Studies (post-2010) (l-165041) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 91 | 0 | 47 |
Protein | Taxonomy | sb 203580 (IC50) | l-165041 (IC50) |
---|---|---|---|
Peroxisome proliferator-activated receptor delta | Homo sapiens (human) | 0.0126 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, X; Jiang, B; Liang, P; Xiao, X; Zhang, B | 1 |
1 other study(ies) available for sb 203580 and l-165041
Article | Year |
---|---|
Enhancement of PPAR-beta activity by repetitive low-grade H(2)O(2) stress protects human umbilical vein endothelial cells from subsequent oxidative stress-induced apoptosis.
Topics: Apoptosis; Cell Line; Endothelial Cells; Humans; Hydrogen Peroxide; Imidazoles; NF-kappa B; Oligonucleotides, Antisense; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptides; Phenoxyacetates; PPAR-beta; Pyridines; Signal Transduction; Stress, Physiological; Transcriptional Activation; Umbilical Veins | 2009 |